doi: 10.1042/BSR20181995 35 FangBLiuFYuXLuoJZhangXZhangTet al
"MOUNJARO is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)." Eli Lilly and Company If you or your family has a history of MEN 2, genetic testing can confirm the diagnosis
5,6 GLP-1 treatments have also shown the ability to curb hunger, opening their potential use for obesity
A recent study among older Americans identified groups that are not getting enough protein
Supplementary Table 2 Correlation of changes in eGFR at week 104 with changes in body weight, blood pressure and HbA1c
However, fat grafting can be unpredictable in some cases, as not all the fat cells survive the transfer, which can lead to partial resorption of the injected fat